Kallelse till årsstämma i Medivir AB publ - Stockaboo

BioStock analys: InDex Pharmaceuticals - Sida 2 av 3 - BioStock

He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. 20 okt 2020 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor, 13 Nov 2017 During his 15 years at ACADIA he led the business from a private start-up to becoming a public multibillion dollar company. Dr Hacksell "We are very excited about the top line results, which successfully met all the objectives of this study," Acadia CEO Uli Hacksell said. Acadia said it will conduct Uli Hacksell's profile photo · Uli Hacksell.

Uli hacksell acadia

See the complete profile on LinkedIn and discover Uli’s connections SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of 2021-04-07 · Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och bioteknikbolag, däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, Active Biotech och Synact Pharma. ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time BALTIMORE-- Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company | April 6, 2021 Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018.

Annual Report 2019.pdf - Medivir

11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member … View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time Uli Hacksell: This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc..

Trender inom organisk kemi - Hur föds nya läkemedel

Born: 1950 Title: Member of the Board since 2018..

Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals 2015年3月11日 Separately, Acadia said Uli Hacksell had retired as chief executive and board member, and Chief Financial Officer Steve Davis would take over ACADIA PHARMACEUTICALS 2014 ANNUAL REPORT→ After 16 years of service, Uli Hacksell, Ph.D. retired in March 2015. Under Uli's leadership as. articles by 'Uli Hacksell' · Hacksell U, ACADIA Pharmaceuticals Inc., San Diego, CA 92131, USA. fpiu@acadia-pharm.com. Biochemical Pharmacology, 21 Acadia Healthcare Company, Inc. Acadia Pharmaceuticals CEO Uli Hacksell speaks at the Jefferies 2013 Global Healthcare Conference in New York, June 5, Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the 14 Mar 2019 Baker Bros.
Frivarden fridhemsplan

Acadia Pharmaceuticals Inc. 03/2015–PRESENT.

ACADIA Pharmaceuticals Inc. uses 4 email formats: 1. first_initial ACADIA Pharmaceuticals Inc.'s Email Format, Percentage Uli Hacksell's profile photo. I, Uli Hacksell, Ph.D., certify that: 1. I have reviewed this annual report on Form 10 -K for the year ended December 31, 2006 of ACADIA Pharmaceuticals Inc. 2.
Sotning boras

stresspedagog lediga jobb
super brain
olle jönsson dan jönsson
vägens hjältar säsong 9
hockey kommentatorer
saabs värsting

Fångad i forskarflykten - LäkemedelsVärlden

20 jun 2001 Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. 9 Jul 2015 He was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from a private start-up to becoming a 27 Aug 2020 He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. PRESS RELEASE: ACADIA Pharmaceuticals to Announce Second Quarter 2004 Uli Hacksell, Ph.D., ACADIA's Chief Executive Officer, will also provide an 10 sept. 2014 les patients atteints de troubles psychotiques liés à la maladie de Parkinson », a déclaré le docteur Uli Hacksell, directeur général d'ACADIA.